IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

VALENTI, LUCA VITTORIO CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 44.342
EU - Europa 41.534
NA - Nord America 40.800
Continente sconosciuto - Info sul continente non disponibili 4.539
SA - Sud America 4.528
AF - Africa 902
OC - Oceania 432
Totale 137.077
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 38.261
CN - Cina 16.580
GB - Regno Unito 11.514
IT - Italia 9.305
SG - Singapore 8.854
DE - Germania 5.503
BD - Bangladesh 3.785
HK - Hong Kong 3.241
BR - Brasile 3.087
RU - Federazione Russa 2.972
SE - Svezia 2.668
VN - Vietnam 2.307
IN - India 2.024
FR - Francia 1.773
JP - Giappone 1.669
TR - Turchia 1.592
NL - Olanda 1.451
CA - Canada 1.268
FI - Finlandia 1.102
KR - Corea 1.090
IE - Irlanda 886
ES - Italia 833
MX - Messico 830
ID - Indonesia 724
UA - Ucraina 695
PL - Polonia 573
TW - Taiwan 565
CO - Colombia 424
AU - Australia 408
AR - Argentina 343
BE - Belgio 301
GR - Grecia 285
DK - Danimarca 282
AT - Austria 275
EU - Europa 245
EG - Egitto 233
TH - Thailandia 215
CH - Svizzera 206
IR - Iran 200
PK - Pakistan 200
CL - Cile 198
RO - Romania 173
CI - Costa d'Avorio 167
IQ - Iraq 159
PT - Portogallo 156
PE - Perù 152
SA - Arabia Saudita 135
EC - Ecuador 132
MY - Malesia 125
IL - Israele 124
PH - Filippine 114
ZA - Sudafrica 109
VE - Venezuela 92
DZ - Algeria 77
UZ - Uzbekistan 77
CZ - Repubblica Ceca 76
CR - Costa Rica 71
HU - Ungheria 66
AE - Emirati Arabi Uniti 61
JO - Giordania 57
NO - Norvegia 57
BG - Bulgaria 56
JM - Giamaica 54
MA - Marocco 54
RS - Serbia 52
KE - Kenya 43
KZ - Kazakistan 43
TN - Tunisia 43
LT - Lituania 39
NP - Nepal 39
HR - Croazia 38
LK - Sri Lanka 38
BO - Bolivia 37
GT - Guatemala 37
HN - Honduras 37
PA - Panama 35
SI - Slovenia 35
PR - Porto Rico 33
SK - Slovacchia (Repubblica Slovacca) 31
PY - Paraguay 30
TT - Trinidad e Tobago 30
UY - Uruguay 28
AZ - Azerbaigian 26
LB - Libano 26
MN - Mongolia 26
NI - Nicaragua 26
MM - Myanmar 25
LU - Lussemburgo 24
NZ - Nuova Zelanda 24
ET - Etiopia 23
SV - El Salvador 23
SY - Repubblica araba siriana 23
DO - Repubblica Dominicana 22
MO - Macao, regione amministrativa speciale della Cina 21
GE - Georgia 20
NG - Nigeria 20
OM - Oman 20
SN - Senegal 20
LV - Lettonia 19
QA - Qatar 19
Totale 132.386
Salva come PNG Salva come JPEG
Città #
Southend 10.030
Singapore 5.090
Ashburn 3.877
Hong Kong 2.618
Houston 2.369
Milan 2.331
San Jose 2.128
Beijing 2.112
Council Bluffs 1.869
Dallas 1.809
Chandler 1.720
Hanover 1.375
Santa Clara 1.279
Seattle 1.276
Los Angeles 1.260
Frankfurt am Main 1.089
Fairfield 1.012
New York 981
Shanghai 937
Princeton 897
Wilmington 886
Dublin 859
Hefei 744
Ho Chi Minh City 733
Guangzhou 727
Nanjing 680
Istanbul 603
Bengaluru 596
Helsinki 591
Ann Arbor 587
Rome 580
Tokyo 579
Hanoi 540
Buffalo 532
Woodbridge 527
Munich 519
Lauterbourg 518
Dearborn 503
Boardman 501
Moscow 488
Cambridge 477
Hangzhou 474
Jacksonville 458
Toronto 449
Jakarta 424
São Paulo 389
Redwood City 366
Warsaw 331
Des Moines 316
Sunnyvale 274
Redmond 272
Mountain View 270
Chicago 264
Phoenix 263
Tianjin 261
Wuhan 256
Seoul 250
Chengdu 249
The Dalles 244
Naples 235
Taipei 233
Changsha 230
Bogotá 229
Shenyang 224
Andover 213
Columbus 212
Jinan 205
Berlin 201
Shenzhen 199
Amsterdam 188
Atlanta 186
Nuremberg 185
Serra 185
London 184
Turin 172
Sakarya 171
Cangzhou 168
Fuzhou 167
Abidjan 165
Somerville 163
Madrid 162
Chongqing 154
Montreal 154
Bologna 144
Paris 143
Bari 141
Melbourne 138
Boston 136
Nanchang 136
Brooklyn 134
Mumbai 133
Rio de Janeiro 133
San Diego 133
Vienna 133
Ankara 132
Zhengzhou 119
Grafing 117
Mexico City 117
Santiago 117
Athens 116
Totale 71.446
Salva come PNG Salva come JPEG
Nome #
A multisociety Delphi consensus statement on new fatty liver disease nomenclature 6.961
A new definition for metabolic dysfunction-associated fatty liver disease : an international expert consensus statement 4.376
Nonalcoholic Fatty Liver Disease in Children 3.728
EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) 2.492
PNPLA3 as a therapeutic target for fatty liver disease : the evidence to date 2.092
The first MASH drug therapy on the horizon: Current perspectives of resmetirom 1.841
Risk of obstructive sleep apnea with daytime sleepiness is associated with liver damage in non-morbidly obese patients with nonalcoholic Fatty liver disease 1.657
A second update on mapping the human genetic architecture of COVID-19 1.574
Mapping the human genetic architecture of COVID-19 1.268
Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease 1.148
COVID-19 and liver disease 872
Statin use and nonalcoholic steatohepatitis in at risk individuals 811
Hepatic Fat-Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAs 754
Dietary anthocyanins as nutritional therapy for nonalcoholic fatty liver disease 726
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 648
Iron biology 645
Preliminary evidences of safety and efficacy of flavonoids- and omega 3-based compound for muscular dystrophies treatment: a randomized double-blind placebo controlled pilot clinical trial. 642
The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development : a potential therapeutic target? 632
The I148M variant of PNPLA3 reduces the response to docosahexaenoic acid in children with non-Alcoholic fatty liver disease 583
Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis 566
Leptin, Resistin, and Proprotein Convertase Subtilisin/Kexin Type 9: The Role of STAT3 525
Hepcidin levels in chronic hemodialysis patients : A critical evaluation 515
Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma 496
Genetic variation in HSD17B13 reduces the risk of developing cirrhosis and hepatocellular carcinoma in alcohol misusers 486
Benzodiazepines induce hyperglycemia in rats by affecting peripheral disposal of glucose 472
The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation 472
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals 453
PNPLA3 I148M Polymorphism, Clinical Presentation, and Survival in Patients with Hepatocellular Carcinoma 442
Prognostic impact of diabetes and prediabetes on survival outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial 439
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 438
Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patients 423
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent 415
Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver 415
PNPLA3 I148M polymorphism and progressive liver disease 411
HFE mutations and iron in hemodialysis patients 409
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models 408
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study 404
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver 401
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 394
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 392
Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease 385
DIETARY IRON OVERLOAD INDUCES VISCERAL ADIPOSE TISSUE INSULIN RESISTANCE: SYNERGY WITH OBESITY IN INDUCING SYSTEMIC INSULIN RESISTANCE 372
Adverse effect of PNPLA3 p.I148M genetic variant on kidney function in middle-aged individuals with metabolic dysfunction 367
Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression : An Observational Study in Patients with Nonalcoholic Fatty Liver Disease 350
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 344
Hepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis 342
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis 338
Global Burden of Major Chronic Liver Diseases in 2021 337
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease 335
Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease 334
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease 334
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 334
Hepatic estrogen receptor alpha drives masculinization in post-menopausal women with metabolic dysfunction-associated steatotic liver disease 333
Interaction between PNPLA3 I148M variant and age at infection in determining fibrosis progression in chronic hepatitis C 332
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker 332
Epicardial Adipose Tissue (EAT) thickness is associated with cardiovascular and liver damage in nonalcoholic fatty liver disease 332
The rs2294918 E434K variant modulates PNPLA3 expression and liver damage 330
β-Klotho gene variation is associated with liver damage in children with NAFLD 330
High fat diet subverts hepatocellular iron uptake determining dysmetabolic iron overload 327
Complement activation and endothelial perturbation parallel COVID-19 severity and activity 326
Response of an Italian reference institute to research challenges regarding a new pandemic: COVID-19 network 323
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection 322
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 321
Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients with Nonalcoholic Fatty Liver Disease 320
Relationship between Helicobacter pylori infection and risk of metabolic dysfunction-associated steatotic liver disease: An updated meta-analysis 319
The hand arthropathy of hereditary hemochromatosis is strongly associated with iron overload 314
The i148m Pnpla3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls 312
Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention 307
A 360-degree overview of paediatric NAFLD: Recent insights 306
Iron stores, hepcidin, and aortic stiffness in individuals with hypertension 305
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 303
DIETARY IRON OVERLOAD INDUCES VISCERAL ADIPOSE TISSUE INSULIN RESISTANCE ASSOCIATED WITH HYPER-RESISTINEMIA, AND SYNERGIZES WITH OBESITY IN INDUCING SYSTEMIC INSULIN RESISTANCE 302
PNPLA3 I148M polymorphism, etiology, and clinical features of hepatocellular carcinoma 301
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 300
PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis 298
Effetti della somministrazione di benzodiazepine all’induzione dell’anestesia sulla glicemia plasmatica: studio sperimentale animale 297
Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations 297
Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy 295
The A736V TMPRSS6 Polymorphism Influences Hepatic Iron Overload in Nonalcoholic Fatty Liver Disease 294
Staphylococcus haemolyticus superinfection of Legionella pneumonia during infliximab therapy 292
Carotid artery intima-media thickness in nonalcoholic fatty liver disease 292
Iron overload impairs the migratory ability of a model of immature and migratory GnRH neurons 285
Liver fat accumulation is associated with circulating PCSK9 levels 285
The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients : TMPRSS6 and hepcidin in hemodialysis 284
Acquired hepatocerebral degeneration (AHD) : a peculiar neurological impairment in advanced chronic liver disease 282
Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling—a propensity score-adjusted observational study 281
Beyond fat accumulation, NAFLD genetics converges on lipid droplet biology 280
Interleukin 28B genotype and insulin resistance in chronic hepatitis C patients 278
Risk of NASH and severe fibrosis in patients with NAFLD and low visceral adiposity 276
Dietary iron overload induces visceral adipose tissue insulin resistance and hyper-resistinemia, and synergizes with obesity and fatty liver in inducing systemic insulin resistance 274
Homozygosity for the PNPLA3/Adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease 273
α1-Antitrypsin mutations in NAFLD : high prevalence and association with altered iron metabolism but not with liver damage 272
Hepatic notch signaling correlates with insulin resistance and nonalcoholic fatty liver disease 272
Particulate matter phagocytosis induces tissue factor in differentiating macrophages 271
Emergency Lung Transplantation after {COVID}-19: Immunopathological Insights on Two Affected Patients 271
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 271
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women 271
Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up 269
Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease 269
MAFLD vs NAFLD : let the contest begin! 269
Totale 61.293
Salva come PNG Salva come JPEG
Categoria #
all - tutte 334.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 334.299
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.749 0 0 568 828 738 706 782 669 1.001 698 641 1.118
2022/20238.035 900 738 668 720 864 1.386 307 558 803 190 487 414
2023/20248.119 436 653 425 532 1.529 530 576 469 324 519 936 1.190
2024/202523.524 1.202 1.943 951 1.982 1.661 1.402 1.364 2.259 1.871 2.309 2.501 4.079
2025/202647.265 4.058 3.240 4.736 3.612 3.783 2.901 4.820 2.789 4.651 3.393 4.916 4.366
2026/20277.151 3.496 3.645 10 0 0 0 0 0 0 0 0 0
Totale 137.077